1. Home
  2. SAGE vs MSC Comparison

SAGE vs MSC Comparison

Compare SAGE & MSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • MSC
  • Stock Information
  • Founded
  • SAGE 2010
  • MSC 2000
  • Country
  • SAGE United States
  • MSC Hong Kong
  • Employees
  • SAGE N/A
  • MSC N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • MSC Hotels/Resorts
  • Sector
  • SAGE Health Care
  • MSC Consumer Discretionary
  • Exchange
  • SAGE Nasdaq
  • MSC Nasdaq
  • Market Cap
  • SAGE 571.7M
  • MSC 572.0M
  • IPO Year
  • SAGE 2014
  • MSC 2018
  • Fundamental
  • Price
  • SAGE $9.08
  • MSC $4.40
  • Analyst Decision
  • SAGE Hold
  • MSC
  • Analyst Count
  • SAGE 18
  • MSC 0
  • Target Price
  • SAGE $10.06
  • MSC N/A
  • AVG Volume (30 Days)
  • SAGE 2.8M
  • MSC 9.2K
  • Earning Date
  • SAGE 07-30-2025
  • MSC 08-12-2025
  • Dividend Yield
  • SAGE N/A
  • MSC N/A
  • EPS Growth
  • SAGE N/A
  • MSC N/A
  • EPS
  • SAGE N/A
  • MSC N/A
  • Revenue
  • SAGE $47,404,000.00
  • MSC $650,708,000.00
  • Revenue This Year
  • SAGE $102.21
  • MSC $8.92
  • Revenue Next Year
  • SAGE $43.01
  • MSC N/A
  • P/E Ratio
  • SAGE N/A
  • MSC N/A
  • Revenue Growth
  • SAGE N/A
  • MSC 19.57
  • 52 Week Low
  • SAGE $4.62
  • MSC $2.30
  • 52 Week High
  • SAGE $13.47
  • MSC $9.30
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 71.54
  • MSC 79.35
  • Support Level
  • SAGE $9.04
  • MSC $3.05
  • Resistance Level
  • SAGE $9.30
  • MSC $3.47
  • Average True Range (ATR)
  • SAGE 0.15
  • MSC 0.35
  • MACD
  • SAGE 0.05
  • MSC 0.18
  • Stochastic Oscillator
  • SAGE 91.35
  • MSC 86.87

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About MSC Studio City International Holdings Limited

Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.

Share on Social Networks: